Global Auto Disable Syringes Market, By Mechanism (Retractable, Non-Retractable, Others), Clinical Indication (Vaccines, Infectious diseases, Inflammatory/Auto-Immune Diseases, Others), Application (Blood Collection, Vaccination, Drug Delivery, Others), End User (Hospitals, Clinics, Diagnostic Laboratories, Ambulatory Surgical Centers, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
The auto disable syringes market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 27.43 billion by 2028 and is expected grow at a CAGR of 10.95% in the above mentioned forecast period.
Auto disable syringes are the type of single use syringe specially designed to block the barrel from depressing again or break the plunger after a single use. These are the kind of safety syringes intended to avoid reuse of syringes.
The high risk of infection and transmission of deadly ailments such as HIV, blood borne diseases and viral hepatitis is amongst the significant factors expected to fuel the growth and demand of auto disable syringes market. In addition, the rise in needle stick injuries and high level of security and safety for patients are also anticipated to push the growth in the global auto disable syringes market over the forecast period of 2021 to 2028. Likewise, the rapid increase in awareness regarding safe healthcare delivery and prevention of infections and communicable diseases and high adoption of preventive care strategies in health care organizations are also projected to lift the growth of the market. Furthermore, the rise in increase in awareness concerning the disadvantages of unsafe syringes is also expected to act as significant factors which will flourish the growth of the auto disable syringes market.
The rapid technological advancements, stringent growth regularities by government and rise in research and activities are expected to offer significant growth opportunities for the auto disable syringes market in the forecast period of 2021 to 2028.
However, the decreased value and lack of knowledge in emerging economies are estimated to limit the growth of the auto disable syringes market, whereas, the high cost of procurement and raw materials can challenge the growth of the auto disable syringes market.
This auto disable syringes market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the auto disable syringes market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Auto Disable Syringes Market Scope and Market Size
The auto disable syringes market is segmented on the basis of mechanism, clinical indication, application and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- The mechanism segment of the auto disable syringes market is segmented into retractable, non-retractable and others. Retractable has further been segmented into automatic retractable and manually retractable. Non-retractable has further been segmented into slip, lock and needle covers.
- Based on clinical indication, the auto disable syringes market is segmented into vaccines, infectious diseases, inflammatory/auto-immune diseases and others.
- On the basis of application, the auto disable syringes market is segmented into blood collection, vaccination, drug delivery and others.
- On the basis of end user, the auto disable syringes market is segmented into hospitals, clinics, diagnostic laboratories, ambulatory surgical centers and others.
Auto Disable Syringes Market Country Level Analysis
The auto disable syringes market is analyzed and market size insights and trends are provided by country, mechanism, clinical indication, application and end user as referenced above.
The countries covered in the auto disable syringes market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.
North America region leads the auto disable syringes market owing to the new product launches, rapid technological developments along with the high adoption of blood collection and blood drawing technologies. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the rise in product launch in emerging economies and rapid increase in demand for safe administration of therapeutics in hospitals and clinics.
The country section of the auto disable syringes market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The auto disable syringes market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for auto disable syringes market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the auto disable syringes market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Auto Disable Syringes Market Share Analysis
The auto disable syringes market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to auto disable syringes market.
The major players covered in the auto disable syringes market report are BD, ISCON SURGICALS LTD., AlShifa Medical Products Co., Hindustan Syringes & Medical Devices Ltd, Retractable Technologies, Inc., Smiths Group plc, Baxter, B. Braun Melsungen AG, Terumo Europe BV, Medtronic, Hamilton Company, PharmaJet, VOGT Medical, SANAVITA PHARMACEUTICALS GMBH, JMI Syringes & Medical Devices Limited, AdvaCare Pharma, ZIBO EASTMED HEALTHCARE PRODUCTS CO., LTD., SWARG PHARMA, Nipro Medical Corporation, and Boston Scientific Corporation, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Auto Disable Syringes Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.